Research for Impact
Urgent Preliminary Yellow Card Report on Data up to 26 May 2021
For all things ivermectin; FAQs, videos, evidence, and other links, please visit www.bird-group.org. All the below materials are being migrated to the BiRD Group website.
IICC Conference April 24 and 25, 2021
The conference has been recorded. Please go to for the recordings or click the button. Please see below Dr Lawrie's powerful closing speech.
Dr Lawrie's messages
Links to subtitled messages
Message to the PUBLIC
Message to DOCTORS
For your MP
For your GP
Nothing on this Website provides medical advice or any form of diagnosis or treatment of any kind to web users. Medical decisions should be made by the patient’s physician who can consider a review of the BIRD materials (www.bird-group.org) and knowledge of the patient’s medical history and condition. All information provided on the E-BMC website or in connection with the Website are offered to promote consideration by trained health care professionals of possible treatments and for general informational purposes and are not medical advice to users. Errors and Omissions excepted.
Please edit and use these to send to your Member of Parliament and your GP. Click and they will download automatically.
Summary of evidence
British Ivermectin Recommendation Development Panel – Response to EMA Statement on Ivermectin for Covid-19
Read the rebuttal to the European Medicines Agency's pronouncement on ivermectin.
BIRD 3 Meeting Sat 20 March
Public Survey Results
Here are the rusults of the public survey of the BIRD EtD framework prentation on the 18-2-21
Dr David Chesler's letter to the NIH
British Ivermectin Recommendation Development Group Webinar was held on the 20th February 2021
What was the aim of the meeting?
To review the evidence on Ivermectin to potentially prevent and treat covid-19, with a view to reaching a consensus and making recommendation/s on its further investigation or use or not. The GDG voted to recommend ivermectin against covid-19.
13 January 2021
British Ivermectin Recommendation Development (BIRD) Meeting held Wednesday 13th January 2021
The BIRD meeting was convened by Dr. Tess Lawrie in order to present the findings from her rapid systematic review and meta-analysis of studies on the use of ivermectin to prevent and treat COVID-19.
Dr. Lawrie presented evidence in the form of a DECIDE evidence-to-decision framework, a format used by the World Health Organization for the development of guidelines and recommendations in medical practice.
Twenty experts from around the world and the UK attended the meeting, including 13 clinicians, and seven representatives from the public.
British Ivermectin Recommendation Development (BIRD) Group draft Evidence to Decision (EtD) framework.
03 January 2021
Covid-19 information for health professionals and policymakers:
Ivermectin reduces the risk of death from COVID-19 - A rapid review and meta-analysis in support of the recommendation of the Front Line COVID-19 Critical Care Alliance
The Evidence-Based Medicine Consultancy Ltd is an independent medical research company that makes meaningful contributions to the quality of healthcare globally through rigorous research and innovative healthcare research methodology.
We conduct original research and provide research support to national and international health organisations, research teams, healthcare professionals and service users with the best possible evidence to inform healthcare decision-making.
For healthcare guideline development, we conduct evidence syntheses to inform stakeholder decision-making. We are also actively involved in the innovation and evolution of guideline methodology to improve the applicability and implementation of healthcare recommendations and guidelines.
Guideline development and derivative products
Cochrane and other systematic reviews
Clinical trial protocols
User testing studies
Teaching videos and promotional material
Clinical practice manuals
Manuscript writing services
Expertise in evidence synthesis and scientific writing.
Expertise in guideline development methodology.
Extensive network of expert collaborators globally.
Experience in low, middle and high-income countries and different settings.
High level of scientific integrity.
Committed to meeting deadlines.
Excellent reputation for creative solutions.
We have many happy clients.
Why use us
Tess (MBBCh, DFSRH, PhD), as director of E-BMC Ltd, is committed to improving the quality of healthcare through rigorous research. Her range of research expertise, based on research experience in both developing and developed countries, uniquely positions her to evaluate and design research for a variety of healthcare settings. Tess is a frequent member of technical teams responsible for developing international guidelines. Her peer-reviewed publications have received in excess of 2000 citations and her ResearchGate score is among the top 5% of ResearchGate members.
Tess (MBBCh, DFSRH, PhD), as director of E-BMC Ltd, is committed to improving the quality of healthcare through rigorous research. Her range of research expertise, based on research experience in both developing and developed countries, uniquely positions her to evaluate and design research for a variety of healthcare settings. Tess is a frequent member of technical teams responsible for developing international guidelines. Her peer-reviewed publications have received in excess of 3000 citations and her ResearchGate score is among the top 5% of ResearchGate members.
Ewelina (MSc, PhD) is an experienced systematic reviewer whose expertise includes the methodology of meta-analyses using individual participant and test accuracy data. She also has considerable experience in managing evidence synthesis projects and their teams.
Education and work experience:
Therese, PhD BSc (econ), is a systematic reviewer with considerable experience in Cochrane and GRADE methodology. Previously she worked with the Cochrane Pregnancy and Childbirth Group in Liverpool where she was frequently involved in international healthcare guideline development.
Claire Mock - Muñoz de Luna
Claire (MSc, PhD) is an experienced Public Health researcher with expertise in health inequalities, migrant and ethnic minority health, and public health policies and institutions. She has substantial international experience in both academic and front-line settings, where she has conducted fieldwork, evidence synthesis, qualitative methods, policy analysis, project management, and advocacy work.
Publications and other supported projects
Please fill in the form or email us at
Please note that neither this site nor E-BMC Ltd retains any information entered in this form.
Please note that due to the high volume of emails we will do our best to respond in three days. Thanks
Bath, United Kingdom